Scotland: £5.1 million to fund private hip & knee surgery:
This article was originally published in Clinica
Executive Summary
Scotland is to spend £5.1m ($8.1m) in 2003-04 to enable the National Health Service to use the private sector to perform hip and knee replacement surgery. The initiative will be used to treat some 590 patients with waits of over six months for these procedures. Some 500 patients have been treated in private hospitals under a similar initiative in 2002-03, at a cost of £4m. The National Waiting Times Unit has provisionally booked spare capacity in private hospitals. These include Ross Hall and Nuffield in Glasgow, Murrayfield in Edinburgh, Carrick Glen in Ayr, Kings Park in Stirling, Albyn in Aberdeen and Fernbrae in Dundee.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.